Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00705770 |
The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma |
Drug: Anecortave Acetate Drug: Placebo |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Parallel Assignment |
Estimated Enrollment: | 400 |
Study Start Date: | May 2008 |
Estimated Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Placebo Comparator
Placebo treatment with vehicle
|
Drug: Placebo
Placebo treatment with vehicle
|
2: Experimental
Low dose of study medication
|
Drug: Anecortave Acetate
Low dose Sustained release depot suspension
|
3: Experimental
Middle dose of study medication
|
Drug: Anecortave Acetate
Middle dose Sustained release depot suspension
|
4: Experimental
High dose of study medication
|
Drug: Anecortave Acetate
High dose Sustained release depot suspension
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Alcon ( Theresa Landry, Ph.D. ) |
Study ID Numbers: | C-07-58 |
Study First Received: | June 24, 2008 |
Last Updated: | July 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00705770 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Open-Angle Glaucoma Intraocular Pressure Anecortave Acetate |
Glaucoma Eye Diseases Glaucoma, Open-Angle Hypertension Ocular Hypertension |
Glaucoma Eye Diseases Glaucoma, Open-Angle Ocular Hypertension |